BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, Deshpande V, Stone JH. IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) 2013;92:206-16. [PMID: 23793110 DOI: 10.1097/MD.0b013e31829cce35] [Cited by in Crossref: 117] [Cited by in F6Publishing: 38] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Wadiwala MF, Ali L, Khan A, Alhatou M. The great imposter: A case report of IgG4‐RD hypertrophic pachymeningitis with skull lytic lesion and pulmonary nodules. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5470] [Reference Citation Analysis]
2 Winkel M, Lawton CD, Sanusi OR, Horbinski CM, Dahdaleh NS, Smith ZA. Neuro-surgical considerations for treating IgG4-related disease with rare spinal epidural compression. Surg Neurol Int 2018;9:209. [PMID: 30488007 DOI: 10.4103/sni.sni_156_18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 Yoon BN, Kim SJ, Lim MJ, Han JY, Lee KW, Sung JJ, Ha CK, Choi SH. Neuro-Behçet's Disease Presenting as Hypertrophic Pachymeningitis. Exp Neurobiol 2015;24:252-5. [PMID: 26412975 DOI: 10.5607/en.2015.24.3.252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
4 El-Nayir M, Subramanian A, Ali Z, Howlett D. IgG4-mediated sclerosing fibroinflammatory disease presenting as inflammatory breast malignancy. BJR Case Rep 2019;5:20180041. [PMID: 31555465 DOI: 10.1259/bjrcr.20180041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Seegobin K, Moustafa MA, Gannon N, Keller K, Hastings J, Gupta V, Tun HW, Jiang L. Successful treatment of IgG4-related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab. Clin Case Rep 2021;9:1610-4. [PMID: 33768900 DOI: 10.1002/ccr3.3855] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Schubert RD, Wood M, Levin MH, Perry A, Gelfand JM. The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum. Neurol Neuroimmunol Neuroinflamm 2016;3:e197. [PMID: 26770998 DOI: 10.1212/NXI.0000000000000197] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sankowski R, Lützen N, Hubbe U, Prinz M, Urbach H, Erny D, Taschner CA. Freiburg Neuropathology Case Conference : A 56-year-old Man Presenting with Progressive Gait Disorder, Neck Pain, and Lower Cranial Nerve Palsy. Clin Neuroradiol 2021;31:1215-21. [PMID: 34767051 DOI: 10.1007/s00062-021-01114-1] [Reference Citation Analysis]
8 Maamri K, Taieb MAH, Elkahla G, Hadhri R, Dermoul M. Immunoglobulin G4-related disease presenting as an intracranial mass extended from the infratemporal fossa. Surg Neurol Int 2022;13:224. [PMID: 35673662 DOI: 10.25259/SNI_149_2022] [Reference Citation Analysis]
9 Li HX, Zuo L, Peng XX, Zong Q, Zhang K, Liu YZ, Wang H, Han GL. Immunoglobulin G4-related hypertrophic pachymeningitis with spinal cord compression: A case report. J Neuroimmunol 2020;347:577325. [PMID: 32731049 DOI: 10.1016/j.jneuroim.2020.577325] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Perugino CA, Mattoo H, Mahajan VS, Maehara T, Wallace ZS, Pillai S, Stone JH. Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies. Arthritis Rheumatol 2017;69:1722-32. [PMID: 28575535 DOI: 10.1002/art.40168] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
11 Lu Z, Tongxi L, Jie L, Yujuan J, Wei J, Xia L, Yumin Z, Xin L. IgG4-related spinal pachymeningitis. Clin Rheumatol 2016;35:1549-53. [PMID: 26567899 DOI: 10.1007/s10067-015-3104-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
12 Mekinian A, Maisonobe L, Boukari L, Melenotte C, Terrier B, Ayrignac X, Schleinitz N, Sène D, Hamidou M, Konaté A, Guilpain P, Abisror N, Ghrenassia E, Lachenal F, Cevallos R, Roos-Weil R, Du LTH, Lhote F, Larroche C, Bergmann JF, Humbert S, Fraison JB, Piette JC, Guillevin L, Dhote R, Amoura Z, Haroche J, Fain O. Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patients. Medicine (Baltimore) 2018;97:e11413. [PMID: 30045263 DOI: 10.1097/MD.0000000000011413] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
13 Uribe JA, Aggarwal I, Witthayaweerasak J, Liao YJ, Berry GJ, Sab UK, Weyand CM. Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis. J Neuroophthalmol 2018;38:17-23. [PMID: 29059089 DOI: 10.1097/WNO.0000000000000566] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Parsons AM, Aslam F, Grill MF, Aksamit AJ, Goodman BP. Rheumatoid Meningitis: Clinical Characteristics, Diagnostic Evaluation, and Treatment. Neurohospitalist 2020;10:88-94. [PMID: 32373270 DOI: 10.1177/1941874419859769] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
15 Nakano Y, Yamamoto M, Komatsu K, Yagita M, Fujita M. Hypertrophic Pachymeningitis in Sjögren's Syndrome. Intern Med 2018;57:413-5. [PMID: 29093421 DOI: 10.2169/internalmedicine.9406-17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
16 Wong AJ, Planck SR, Choi D, Harrington CA, Troxell ML, Houghton DC, Stauffer P, Wilson DJ, Grossniklaus HE, Dailey RA, Ng JD, Steele EA, Harris GJ, Czyz C, Foster JA, White VA, Dolman PJ, Kazim M, Patel PJ, Edward DP, al Katan H, al Hussain H, Selva D, Yeatts RP, Korn BS, Kikkawa DO, Rosenbaum JT. IgG4 immunostaining and its implications in orbital inflammatory disease. PLoS One 2014;9:e109847. [PMID: 25303270 DOI: 10.1371/journal.pone.0109847] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
17 George MM, Goswamy J, Solanki K, Bhalla R. Infiltrative mass of the skull base and nasopharynx: A diagnostic conundrum. Ann Med Surg (Lond) 2015;4:103-6. [PMID: 25905016 DOI: 10.1016/j.amsu.2015.03.005] [Reference Citation Analysis]
18 Ferreira NR, Vaz R, Carmona S, Mateus S, Pereira P, Fernandes L, Moreira H, Chorão M, Saldanha L, Carvalho A, Campos L. IgG4-related disease presenting with an epidural inflammatory pseudotumor: a case report. J Med Case Rep 2016;10:61. [PMID: 26975393 DOI: 10.1186/s13256-016-0838-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
19 Yao Y, Xu Y, Li X, Song T, Xu W, Duan Y, Liu Y, Zhang X, Tian D. Clinical, imaging features and treatment response of idiopathic hypertrophic pachymeningitis. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.104026] [Reference Citation Analysis]
20 Yu Y, Lv L, Yin SL, Chen C, Jiang S, Zhou PZ. Clivus-involved immunoglobulin G4 related hypertrophic pachymeningitis mimicking meningioma: A case report. World J Clin Cases 2022; 10(18): 6269-6276 [DOI: 10.12998/wjcc.v10.i18.6269] [Reference Citation Analysis]
21 Margolin EA, Gopwani J, Eberhart CG, Blitz AM. Mass confusion in a 30-year-old man. J Neuroophthalmol 2014;34:408-11. [PMID: 25405663 DOI: 10.1097/WNO.0000000000000194] [Reference Citation Analysis]
22 Kim SH, Kang Y, Oh SH, Paik S, Kim JS. Paraplegia in a Patient With IgG4-Related Sclerosing Disease: A Case Report. Ann Rehabil Med 2014;38:856-60. [PMID: 25566488 DOI: 10.5535/arm.2014.38.6.856] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
23 Sireesha Y, Uppin MS, Ganti S, Alugolu R, Mudumba VS, Bhattacharjee S, Neeharika ML, Bastia J, Kanikannan MA. A Series of Biopsy-proven Patients with Immunoglobulin G4-related Neurological Disease. Ann Indian Acad Neurol 2019;22:73-8. [PMID: 30692763 DOI: 10.4103/aian.AIAN_283_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Vakrakou AG, Evangelopoulos ME, Boutzios G, Tzanetakos D, Tzartos J, Velonakis G, Toulas P, Anagnostouli M, Andreadou E, Koutsis G, Stefanis L, Fragoulis GE, Kilidireas C. Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review. Rheumatol Int 2020;40:337-43. [PMID: 31898763 DOI: 10.1007/s00296-019-04502-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Williams MM, Mashaly H, Puduvalli VK, Jin M, Mendel E. Immunoglobulin G4-related disease mimicking an epidural spinal cord tumor: case report. J Neurosurg Spine 2017;26:76-80. [PMID: 27517527 DOI: 10.3171/2016.5.SPINE16119] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Ioannidis P, Parissis D, Bakirtzis C, Karayannopoulou G, Kanitakis J. Isolated IgG4-related hypertrophic pachymeningitis. Acta Neurol Belg 2017;117:569-71. [PMID: 27473176 DOI: 10.1007/s13760-016-0680-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Zhang W, Luo J, Jiao J. Optic nerve involvement in immunoglobulin G4-related disease: A case report. Exp Ther Med 2016;12:111-4. [PMID: 27347025 DOI: 10.3892/etm.2016.3291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Yim SH, Yoon JS, Lee CH, Kim J. Hypertrophic Pachymeningitis and Interstitial Lung Disease in IgG4-Related Disease. J Clin Neurol 2022;18:481-3. [PMID: 35796274 DOI: 10.3988/jcn.2022.18.4.481] [Reference Citation Analysis]
29 Su T, Yang L, Cui Z, Wang SX, Zhao MH. Concurrent IgG4-related tubulointerstitial nephritis and IgG4 myeloperoxidase-anti-neutrophil cytoplasmic antibody positive crescentic glomerulonephritis: A case report. Medicine (Baltimore) 2017;96:e6707. [PMID: 28514287 DOI: 10.1097/MD.0000000000006707] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
30 Swerdlow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JK, Sander B, Ott G, Xerri L, Quintanilla-Martinez L, Campo E. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Arch 2016;468:259-75. [PMID: 26454445 DOI: 10.1007/s00428-015-1858-9] [Cited by in Crossref: 65] [Cited by in F6Publishing: 45] [Article Influence: 9.3] [Reference Citation Analysis]
31 Galetta K, Bhattacharyya S. Acute Neurologic Manifestations of Systemic Immune-Mediated Diseases. Semin Neurol 2021;41:541-53. [PMID: 34619780 DOI: 10.1055/s-0041-1733790] [Reference Citation Analysis]
32 Rosenbaum JT, Choi D, Wilson DJ, Grossniklaus HE, Harrington CA, Sibley CH, Dailey RA, Ng JD, Steele EA, Czyz CN, Foster JA, Tse D, Alabiad C, Dubovy S, Parekh P, Harris GJ, Kazim M, Patel P, White V, Dolman P, Korn BS, Kikkawa D, Edward DP, Alkatan H, Al-Hussain H, Yeatts RP, Selva D, Stauffer P, Planck SR. Parallel Gene Expression Changes in Sarcoidosis Involving the Lacrimal Gland, Orbital Tissue, or Blood. JAMA Ophthalmol 2015;133:770-7. [PMID: 25880323 DOI: 10.1001/jamaophthalmol.2015.0726] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
33 Baptista B, Casian A, Gunawardena H, D'Cruz D, Rice CM. Neurological Manifestations of IgG4-Related Disease. Curr Treat Options Neurol 2017;19:14. [PMID: 28374231 DOI: 10.1007/s11940-017-0450-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
34 Levraut M, Cohen M, Bresch S, Giordana C, Burel-Vandenbos F, Mondot L, Sedat J, Fontaine D, Bourg V, Martis N, Lebrun-Frenay C. Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review. Neurol Neuroimmunol Neuroinflamm 2019;6:e568. [PMID: 31355304 DOI: 10.1212/NXI.0000000000000568] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
35 Charleston L 4th, Cooper W. An Update on Idiopathic Hypertrophic Cranial Pachymeningitis for the Headache Practitioner. Curr Pain Headache Rep 2020;24:57. [PMID: 32803475 DOI: 10.1007/s11916-020-00893-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Solomon EA, Murphy A, Siegel AM, Taylor G. Steroid-Responsive Mania Secondary to Pachymeningitis of the Right Frontal Lobe. J Acad Consult Liaison Psychiatry 2021;62:89-96. [PMID: 33183847 DOI: 10.1016/j.psym.2020.09.011] [Reference Citation Analysis]
37 Pieringer H, Parzer I, Wöhrer A, Reis P, Oppl B, Zwerina J. IgG4- related disease: an orphan disease with many faces. Orphanet J Rare Dis 2014;9:110. [PMID: 25026959 DOI: 10.1186/s13023-014-0110-z] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.8] [Reference Citation Analysis]
38 Al-Mujaini A, Al-Khabori M, Shenoy K, Wali U. Immunoglobulin G4-Related Disease: An Update. Oman Med J 2018;33:97-103. [PMID: 29657677 DOI: 10.5001/omj.2018.20] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
39 van den Elshout-den Uyl D, Spoto CPE, de Boer M, Leiner T, Leavis HL, Leguit RJ. First Report of IgG4 Related Disease Primary Presenting as Vertebral Bone Marrow Lesions. Front Immunol 2019;10:1910. [PMID: 31456806 DOI: 10.3389/fimmu.2019.01910] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
40 Goulam-Houssein S, Grenville JL, Mastrocostas K, Munoz DG, Lin A, Bharatha A, Vlachou PA. IgG4-related intracranial disease. Neuroradiol J 2019;32:29-35. [PMID: 30320530 DOI: 10.1177/1971400918806323] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
41 Joshi S, Masiak A, Zdrojewski Z. Rheumatoid arthritis with pachymeningitis - a case presentation and review of the literature. Reumatologia 2020;58:116-22. [PMID: 32476685 DOI: 10.5114/reum.2020.95368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Kim SH, Kim JS. Immunoglobulin G4-Related Hypertrophic Pachymeningitis Mimicking Chiari Malformation. J Clin Neurol 2016;12:238-40. [PMID: 26541498 DOI: 10.3988/jcn.2016.12.2.238] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
43 Nesbitt C, Willshire L, Quan D, Shaw C, Batchelor P. Leptomeningeal rheumatoid nodules: diagnosis and failed therapeutics. J Clin Neurosci 2015;22:425-8. [PMID: 25533052 DOI: 10.1016/j.jocn.2014.07.031] [Reference Citation Analysis]
44 Dziedzic T, Wojciechowski J, Nowak A, Marchel A. Hypertrophic pachymeningitis. Childs Nerv Syst 2015;31:1025-31. [PMID: 25771924 DOI: 10.1007/s00381-015-2680-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
45 Marrodan M, Bensi C, Alessandro L, Muggeri AD, Farez MF. Chronic and Subacute Meningitis: Differentiating Neoplastic From Non-Neoplastic Etiologies. Neurohospitalist 2018;8:177-82. [PMID: 30245767 DOI: 10.1177/1941874418773924] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
46 Schuyler AJ, Wilson JM, Tripathi A, Commins SP, Ogbogu PU, Kruzsewski PG, Barnes BH, McGowan EC, Workman LJ, Lidholm J, Rifas-Shiman SL, Oken E, Gold DR, Platts-Mills TAE, Erwin EA. Specific IgG4 antibodies to cow's milk proteins in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol 2018;142:139-148.e12. [PMID: 29678750 DOI: 10.1016/j.jaci.2018.02.049] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
47 Hamano H, Tanaka E, Ishizaka N, Kawa S. IgG4-related Disease - A Systemic Disease that Deserves Attention Regardless of One's Subspecialty. Intern Med 2018;57:1201-7. [PMID: 29279491 DOI: 10.2169/internalmedicine.9533-17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
48 Jang Y, Lee ST, Jung KH, Chu K, Lee SK. Rituximab Treatment for Idiopathic Hypertrophic Pachymeningitis. J Clin Neurol 2017;13:155-61. [PMID: 28271643 DOI: 10.3988/jcn.2017.13.2.155] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
49 Woo PYM, Ng BCF, Wong JHM, Ng OKS, Chan TSK, Kwok NF, Chan KY. The protean manifestations of central nervous system IgG4-related hypertrophic pachymeningitis: a report of two cases. Chin Neurosurg J 2021;7:13. [PMID: 33536053 DOI: 10.1186/s41016-021-00233-5] [Reference Citation Analysis]
50 Mejico LJ. IgG4-related ophthalmic disease. Saudi J Ophthalmol 2015;29:53-6. [PMID: 25859140 DOI: 10.1016/j.sjopt.2014.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
51 Joshi D, Jager R, Hurel S, Pereira SP, Johnson GJ, Chapman M, Fowler R, Winstanley A, Losseff N, Webster GJ. Cerebral involvement in IgG4-related disease. Clin Med (Lond) 2015;15:130-4. [PMID: 25824063 DOI: 10.7861/clinmedicine.15-2-130] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
52 Cação G, Calejo M, Alves JE, Medeiros PB, Vila-Cha N, Mendonça T, Taipa R, Silva AM, Damásio J. Clinical features of hypertrophic pachymeningitis in a center survey. Neurol Sci 2019;40:543-51. [PMID: 30588552 DOI: 10.1007/s10072-018-3689-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]